Home

safe_image.php

More teenagers opt for e-cigarettes, hubbly

UCT’s Professor Richard van Zyl-Smit says more and more teenagers smoke e-cigarettes and hubbly-bubbly, a flavoured tobacco, adding that the volume of smoke one inhales from a hubbly is significantly higher than that inhaled from a normal cigarette.
Listen to the interview Radio 702, 1 May 2016

LAMTest_large

UCT Study: Low-cost urine TB test reduces TB death-rate

A rapid, and simple to use, low-cost urine sample to test for TB at the bed-side of HIV patients both able and unable to produce sputum, reduced the TB death-rate of patients with advanced HIV. TB treatment can be initiated quicker than if diagnosed using current diagnostic tools.

Read more UCT Faculty of Health Science, 15 March 2016
Read more UCT: Today's news, 16 March 2016

urine_test_for_tb

Urine test improves detection of TB

Tuberculosis often lies undetected in the very patients it is most likely to kill: HIV positive patients. But a urine test could change that.

Read more The Times, 27 January 2016

Prof_Keertan_Dheda

UCT fellow announced: Prof Keertan Dheda

At a ceremony on Tuesday 13 October, UCT announced the names of six new fellows – permanent academic staff who are being recognised by UCT Council for distinguished academic work.

Read more UCT: Today's news, 16 October 2015

antibiotic_resistence

The rise of antibiotic resistance

SABC Live Digital News: live interview with Professor Keertan Dheda.

Watch the interview Newsroom, 21 September 2015

15_anni

15 Year Anniversary:2000 – 2014

On the 7 November 2014, the Institute celebrated its 15 year anniversary. We want to honour those that have supported the Institute in any way; as funders, collaborating in research, partnering in outreach activities, and helping to build, maintain and administer the facility.

Download report

TBTeam_700

Better, quicker, cheaper new TB drug steals the headlines

UCT scientists are part of an international research group, which includes the Universities of Stellenbosch and the Free State, on track to deliver more effective, less expensive and shorter TB treatment using a new combination of drugs.

Read more UCT: Today's news, 12 August 2014

chapelstreet-Tatler

Exciting new start for Chapel Street Clinic

The Chapel Street Clinic in Woodstock has reopened its doors after a R1.4 million upgrade. The project was headed up by the University of Cape Town’s Lung Institute who had been conducting research into TB at the clinic since 2007.

"...now patients will have access to better facilities with better services," Dr Dawson said.

Download article Tatler, 17 July 2014

UCT finalists compete for annual NSTF-BHP Billiton Awards

Eleven UCT researchers have been selected as finalists for the prestigious NSTF-BHP Billiton Awards for 2013/14.

Included in the finalists are: Eric Bateman, Emeritus Professor in the Department of Medicine and director and founder of the UCT Lung Institute and Keertan Dheda, Professor and Head of the Division of Pulmonology, Department of Medicine.

Read more UCT: Today's news, 21 May 2014

kheertan-art

Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study

www.thelancet.com Published online 17 January, 2014

Download article The Lancet, 17 January 2014

Download press release UCT press release

Download press release The Lancet press release

bateman_xray_main2

UCT scientists shine at MRC awards

UCT scientists featured prominently in the Medical Research Council's (MRC) recent merit award ceremony, with "the highest honour in medical research in the country" being conferred onto three high profile academics. Emeritus Professor Eric Bateman, director of the Lung Institute, received a lifetime achievement award in the form of the MRC's platinum medal.

Read more UCT: Today's news, 6 November 2013

dheda-xray

Faster TB test fails to improve prognosis

New ground-breaking work by Prof Dheda's team based at the UCT Lung Institute.

Read more eNCA, 28 October 2013

www.thelancet.com
Download article 1 (pdf) The Lancet, 28 October 2013
Download article 2 (pdf) The Lancet, 28 October 2013

TB-Initiative-main

‘Novel’ trial may lead to shorter TB treatment

A new clinical trial by the UCT Lung Institute's Centre for TB Research Innovation (CTBRI) is not only innovative in design and in its collaborative nature, but it's also the first major African TB study to use a complete source-based electronic data capture and verification system.

Read more UCT: Today's news, 12 June 2013

The Mission of the Institute is to address priority health issues in Southern Africa through education, research and service

 

The Institute is located on the campus of the Faculty of Health Sciences.It provides clinical services and conducts research in the fields of respiratory medicine, tuberculosis, allergy, occupational medicine and dermatology. Special emphases in research are epidemiology, allergy diagnostics, lung physiology, clinical pharmacology, evaluation of novel treatments and community-based interventions for improving disease management and improving health. In association with various departments of the University, it provides training for students in the health professions and collaborates broadly with training and research institutions elsewhere in South Africa and abroad. The public is served by educational and health promotional activities, and by several unique clinical and community services.

Leave a Reply